<DOC>
	<DOCNO>NCT00502801</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety doripenem monohydrate treatment patient nosocomial ( hospital-acquired ) pneumonia .</brief_summary>
	<brief_title>An Effectiveness , Safety , Microbiology Study Doripenem Patients With Nosocomial ( Hospital-acquired ) Pneumonia</brief_title>
	<detailed_description>Nosocomial pneumonia ( NP ) account approximately 15 % hospital-acquired infection . The incidence NP rise patient breathe machine . The death rate NP high 30 % . NP cause bacteria , Pseudomonas aeruginosa , associate increase death rate compare pathogen . Prompt use appropriate antibiotic essential . Compounding issue nosocomial infection increase rate bacteria develop resistance antibiotic . This hospital base trial study doripenem patient nosocomial pneumonia see effective bacteria associate serious bacterial infection . The duration treatment anywhere 8 14 day . Safety evaluation , vital sign laboratory test perform upon enrollment , 4 day therapy , 9 day therapy great 8 day , end therapy , 7 14 day end therapy , 28 35 day end therapy . Adverse event collect throughout study . Clinical response doripenem therapy assess 7 14 day end therapy long-term clinical response doripenem therapy assess 28 35 day end therapy . Doripenem IV administer duration treatment 8 14 day .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<criteria>Patients suffer Nosocomial Pneumonia VentilatorAssociated Pneumonia All patient must hospitalize throughout treatment period Patients must microbiological sample ( respiratory secretion ) suitable culture microscopy Known suspect severe kidney impairment Known suspect liver dysfunction Treatment investigational drug device within 30 day enrollment Patients one following : cystic fibrosis , lung abscess , active tuberculosis Women pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Pneumonia</keyword>
	<keyword>Lung Infection</keyword>
	<keyword>Bacterial Infection</keyword>
	<keyword>Hospital-Acquired Infection</keyword>
	<keyword>Ventilator Infection</keyword>
	<keyword>Antibiotic Therapy</keyword>
</DOC>